Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.16
-2.49 (-1.35%)
At close: Jan 22, 2026, 4:00 PM EST
182.30
+0.14 (0.08%)
After-hours: Jan 22, 2026, 4:58 PM EST
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.82B in the quarter ending September 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to $10.85B, up 13.74% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.85B
Revenue Growth
+13.74%
P/S Ratio
1.90
Revenue / Employee
$193,750
Employees
56,000
Market Cap
20.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
| Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.77B |
| ICON Public Limited Company | 8.10B |
| Agilent Technologies | 6.95B |
| Illumina | 4.29B |
| Mettler-Toledo International | 3.94B |
| Waters | 3.11B |
| Exact Sciences | 3.08B |
| Revvity | 2.81B |
DGX News
- 1 day ago - Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year - PRNewsWire
- 7 days ago - Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect - PRNewsWire
- 9 days ago - Quest Diagnostics Incorporated (DGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 14 days ago - Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 - PRNewsWire
- 16 days ago - Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium - PRNewsWire
- 17 days ago - Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan - PRNewsWire
- 4 weeks ago - Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 6 weeks ago - Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha